Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1227-1234

  Trush, Michael A ^a   Twerdok, Lorraine E ^a,b   Rembish, Stephen J ^a,c   Zhu, Hong ^a   Li, Yunbo ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AMERICAN PETROLEUM INSTITUTE   (United States)

^c Toxicology and Risk Assessment Section   (United States)

Author keywords

1,2 dithiole 3 thione; Bone marrow stromal cells; Chemoprotection; Glutathione; HL 60; Hyd roquinone; ML 1; Quinone reductase; Susceptibility

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; BENZENE; BUTHIONINE SULFOXIMINE; CYTOCHROME P450; DICOUMAROL; GLUTATHIONE; HYDROQUINONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

BIOCHEMISTRY; BLOOD TOXICITY; BONE MARROW CELL; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONFERENCE PAPER; CYTOTOXICITY; DISEASE PREDISPOSITION; ENZYME INDUCTION; MACROPHAGE; MONOCYTE; MYELOPOIESIS; PRIORITY JOURNAL; RISK ASSESSMENT; STROMA CELL; TARGET CELL;

EID: 0030449288     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041227     Document Type: Conference Paper

References (58)

1. Hunter D. The Diseases of Occupations, 6th ed. London:Hodder and Stoughton, 1978.
2. Paustenbach DJ, Bass DR, Price P. Benzene toxicity and assessment, 1991-1992: implications for future regulation. Environ Health Perspect Suppl 101:177-200 (1993).
3. Kensler TW, Helzlsouer KJ. Oltripraz: clinical opportunities for cancer chemoprevention. J Cell Biochem, Suppl 22:101-107 (1995).
4. Greenburg L. Results of medical examination and clinical tests made to discover early signs of benzol poisoning in exposed workers. Public Health Rep 41:1526-1539 (1926).
5. Snyder R, Longacre SL, Witmer C, Kocsis JJ, Andrews LS, Lee EW. Biochemical toxicology of benzene. In: Reviews in Biochemical Toxicology, Vol 3 (Hodgson E, Bend JR, Philpot RM, eds.) New York: Elsevier, 1981;123-153.
6. Johansson I, Ingelman-Sundberg M. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48:5387-5390 (1988).
7. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA. Benzene metabolism by human liver microsomes in relation to cytochrome P-450 2E1 activity. Carcinogenesis 15:1799-1805 (1994).
8. Williams WJ, Bentler E, Erslev AJ, Lichtiman MA. Hematology. 3rd ed. New York:McGraw-Hill, 1983.
9. King AG, Landreth KS, Wierda D. Hydroquinone inhibits bone marrow pre-B cell maturation in vitro. Mol Pharmacol 32:807-812 (1987).
10. Thomas DJ, Reasor MJ, Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol 97:440-453 (1989).
11. Long MW, Wicha MS, eds. The Hematopoietic Microenvironment: the Functional and Structural Basis of Blood Cell Development. Baltimore:Johns Hopkins University Press, 1993.
12. Jones TD, Morris MD, Young RW, Kehlet RA. A cell kinetics model for radiation-induced myelopoiesis. Exp Hematol 21:816-822 (1993).
13. Twerdok LE, Rembish SJ, Trush MA. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol 12:273-281 (1992).
14. Zhu H, Li Y, Trush MA. Characterization of benzo[a]pyrene quinone-induced toxicity to primary cultured bone marrow stromal cells from DBA/2 mice: potential role of mitochondrial dysfunction. Toxicol Appl Pharmacol 13:108-120 (1995).
15. Thomas DJ, Sadler A, Subrahmanyam W, Siegel D, Reasor MJ, Wierda D, Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid-cells. Mol Pharmacol 37:255-262 (1990).
16. Subrahmanyam W, Kolachana P, Smith MT. Metabolism of hydroquinone by myeloperoxidase: mechanisms of stimulation by other phenolic compounds. Arch Biochem Biophys 156:759-763 (1991).
17. Schlosser MJ, Surina RD, Kalf GF. Metabolism of phenol and hydroquinone to reactive products by macrophage peroxidase or purified prostaglandin H-synthase. Environ Health Perspect 82:229-237 (1989).
18. Li Y, Trush MA. Oxidative stress and its relationship to carcinogen activation. In: Oxidative Stress and Aging (Culter R, Packer L, Bertram J, Mori A, eds). Basel:Birkhuser Verlag, 1995;203-220.
19. Li Y, Trush MA. Oxidation of hydroquinone by copper: chemical mechanism and biological effects. Arch Biochem Biophys 300:346-355 (1993).
20. Li Y, Trush MA. Alteration of cellular glutathione as a factor in hydroquinone-induced cytotoxicity to primary cultured bone marrow stromal cells from DBA/2 mice. In Vitro Toxicol 5:59-71 (1992).
21. Zhu H, Li Y, Trush MA. Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: implications for benzene-induced hematotoxicity. J Toxicol Environ Health, 46:183-201 (1995).
22. Longacre SL, Kocsis JJ, Snyder R. Influence of strain differences in mice on the metabolism and toxicity of benzene. Toxicol Appl Pharmacol 60:398-409 (1981).
23. 1 Mice (Gavage Studies). Research Triangle Park, NC:National Toxicology Program, 1986.
24. 1 mice. Toxicol Appl Pharmacol 94:128-140 (1988).
25. Lyons AB, Ashman LK. Monocyte cell lines. In: Human Monocytes (Zembola M, Asherson GL, eds). San Diego: Academic Press, 1989:59-69.
26. Oliveria NL, Kalf GF. Induced differentiation of HL-60 promyelocytic leukemia cells to monocyte/macrophages by hydroquinone, a hematotoxic metabolite of benzene. Blood 79:627-633 (1992).
27. 32P-postlabeling. Carcinogenesis 12:1181-1186 (1991).
28. Chuang LF, Hinton DE, Cheung ATW, Chuang RY. Induction of differentiation in human myeloblastic leukemia ML-1 cells by heptachlor, a chlorinated hydrocarbon insecticide. Toxicol Appl Pharmacol 109:98-107 (1991).
29. Li Y, Lafuente A, Trush MA. Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity. Life Sci 54:901-916 (1994).
30. Li Y, Zhu H, Trush MA. 12-O-Tetradeconylphorbol-13-acetate (TPA)-induced differentiation to monocyte/ macrophages is accompanied by increased xenobiotic detoxifying activities and decreased susceptibility to hydroquinone (HQ)-induced toxicity. Toxicologist 15:302 (1995).
31. Rembish SJ, Craig RW, Trush MA. Characterization of an in vitro model for assessing mitochondrial maturation in monocytic cells. Toxicologist 12:284 (1992).
32. Shertzer HG, Vasiliou V, Liu R-M, Tabor MW, Nebert DW. Enzyme induction by L-buthionine (SR)-sulfoximine in cultured mouse hepatoma cells. Chem Res Toxicol 8:431-436 (1995).
33. Berenblum I. The modifying influence of dichlorethyl sulphide on the induction of tumors in mice by tar. J Pathol Bacteriol 32:425-434 (1929).
34. Wattenberg LW. Chemoprevention of cancer. Cancer Res 45:18 (1985).
35. DeLong MJ, Prochaska HJ, Talalay P. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci USA 83:787-791 (1986).
36. Talalay P, DeLong MJ, Prochaska HJ. Molecular mechanisms in protection against carcinogenesis. In: Cancer Biology and Therapeutics (Cory JG, Szentivani A, eds). New York:Plenum Press, 1987;197-216.
37. Prochaska HJ, Talalay P. Regulation mechanism of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776-4782 (1988).
38. Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver-cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10 (1994).
39. 7-quanine and serum-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Carcinogenesis 13:101-106 (1992).
40. Huggins CB, Ueda N, Russo A. Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proc Natl Acad Sci USA 75:4524-4527 (1978).
41. Huggins C, ed. Experimental Leukemia and Mammary Cancer. Induction, Prevention and Cure. Chicago:University of Chicago Press, 1979.
42. Nebert DW, Jensen NM, Levitt RC, Felton JS. Toxic chemical depression of the bone marrow and possible aplastic anemia explainable on a genetic basis. Clin Toxicol 16:99-122 (1980).
43. Nebert DW, Levitt RC, Jensen NM, Lambert GH, Felton JS. Birth defects and aplastic anemia: differences in polycyclic hydrocarbon toxicity-associated with the Ah locus. Arch Toxicol 39:109-132 (1977).
44. Nebert DW, Jensen NM. Benzo[a]pyrene-initiated leukemia in mice associated with allelic differences at the Ah locus. Biochem Pharmacol 27:149-151 (1970).
45. Rao KP, Nandan BD. Modification of benzo[a]pyrene induced chromosomal damage in mouse bone marrow by vitamin A. Bull Environ Contam Toxicol 45:829-832(1990).
46. Ito Y, Ohnishi S, Fujie K. Chromosome aberrations induced by aflatoxin B1 in rat bone marrow cells in vivo and their suppression by green tea. Mutation Res 222:253-261 (1989).
47. Yang CS, Wang Z-Y. Tea and cancer. J Natl Cancer Inst 85:1038-1049,(1993).
48. Twerdok LE, Trush MA. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res Commun Chem Pathol Pharmacol 67:375-386 (1990).
49. Twerdok LE, Rembish SJ, Trush MA. Studies with 1,2-dithiole-3-thione as a chemoprotector of hydroquinone-induced toxicity to DBA/2-derived bone-marrow stromal cells. Environ Health Perspect 101:172-177 (1993).
50. Kensler TW, Groopman J, Roebuck BD. Chemoprotection by oltripraz and other dithiothiones. In: Cancer Chemoprevention (Wattenberg L, Lipkin M, Boone-W, Kelloff GJ, eds). Boca Raton, FL:CRC Press, 1992;205-226.
51. Renz JF, Kalf GF. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity. Inhibition of conversion of pre-IL-α to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity by IL-α. Blood 78:938-944 (1991).
52. Rembish SJ, Craig RW, Trush MA. Characterization of the effects of hydroquinone on ML-1 cell differentiation. Toxicologist 13:424 (1993).
53. He H, Trush MA. Time and concentration dependency of phorbol ester treatment on mitochondrial superoxide generation during differentiation of ML-1 cells. Toxicologist 15:281 (1995).
54. Rembish SJ, Yang Y, Esterline RE, Seacat A, Trush MA. Lucigenin-derived chemiluminescence as a monitor of mitochondrial maturation and modulation in mononuclear cells. In: In Vitro Toxicology: Mechanisms and New Technology, Vol 8 (Goldbetg AM, ed). New York:Mary Ann Liebert 1991;463-469.
55. Rembish SJ, Trush MA. Further evidence that lucigenin-derived chemiluminescence monitors mitochondrial superoxide generation in rat alveolar macrophages. Free Radic Biol Med 17:117-126 (1994).
56. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA. In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity. Carcinogenesis 16:1519-1527 (1995).
57. Peter R, Bocker RG, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. Hydrolylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem Res Toxicol 3:566-573 (1990).
58. Guengerich FP, Kim D-H, Iwasaki M. Role of human P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179 (1991).